🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
The primary objective of this study is to demonstrate the non-inferiority o...
Status
Completed
Location
Alabama Clinical Therapeutics Site Number : 8400036
Start Date
2018-10-04
Trial ID
NCT03691610
Treatments Being Tested
The purpose of this study was to evaluate the optimal vaccination schedule ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-16
Trial ID
NCT01049035
Treatments Being Tested
Primary Objective: * To demonstrate that ProQuad® can be administered conc...
Status
Completed
Location
Multiple Locations
Start Date
2007-01-12
Trial ID
NCT00432042
Treatments Being Tested
The primary objective of this study was to describe the safety profile of M...
Status
Completed
Location
Birmingham Pediatric Associates-Site Number:8400049
Start Date
2018-09-17
Trial ID
NCT03673462
Treatments Being Tested
This study will evaluate the safety and immune response of the Novartis Men...
Status
Completed
Location
Growing Up Pediatrics
Start Date
2007-03
Trial ID
NCT00474526
This open label randomized study will be conducted to evaluate and/or descr...
Status
Completed
Location
Investigational Site Number : 3560006
Start Date
2023-03-27
Trial ID
NCT05794230
Treatments Being Tested
This Phase III, open-label, randomized, parallel-group, active-controlled, ...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-07
Trial ID
NCT03205371
Treatments Being Tested